| Autor: |
Fettrelet T; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Hosseini A; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Wyss J; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland.; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Boros-Majewska J; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Stojkov D; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Yousefi S; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Simon HU; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland.; Institute of Biochemistry, Brandenburg Medical School, 16816 Neuruppin, Germany. |
| Abstrakt: |
Eosinophils, a type of granulocyte derived from myeloid precursors in the bone marrow, are distinguished by their cytoplasmic granules. They play crucial roles in immunoregulation, tissue homeostasis, and host defense, while also contributing to the pathogenesis of various inflammatory diseases. Although long non-coding RNAs (lncRNAs) are known to be involved in eosinophilic conditions, their specific expression and functions within eosinophils have not been thoroughly investigated, largely due to the reliance on tissue homogenates. In an effort to address this gap, we analyzed publicly available high-throughput RNA sequencing data to identify lncRNAs associated with eosinophilic conditions. Among the identified lncRNAs, ITGB2 antisense RNA 1 ( ITGB2-AS1 ) was significantly downregulated in blood eosinophils from patients with hypereosinophilia. To further explore its role in eosinophil biology, we generated a stable ITGB2-AS1 knockdown in the HL-60 cell line. Interestingly, ITGB2-AS1 deficiency led to impaired eosinophil differentiation, as evidenced by a reduction in cytoplasmic granules and decreased expression of key eosinophil granule proteins, including eosinophil peroxidase (EPX) and major basic protein-1 (MBP-1). Additionally, ITGB2-AS1 -deficient cells exhibited compromised eosinophil effector functions, with reduced degranulation and impaired production of reactive oxygen species (ROS). These findings suggest that ITGB2-AS1 plays a pivotal role in eosinophil differentiation and function, positioning it as a novel regulator in eosinophil biology. |
